Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-23

FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's supplemental application for alfuzosin hydrochloride.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALFUZOSIN HYDROCHLORIDE (alfuzosin hydrochloride)

Snippet

SUPPL AP for ALFUZOSIN HYDROCHLORIDE (ALFUZOSIN HYDROCHLORIDE)